40 Start-Up Device Companies Confirmed to Date to Present at Medtech Insight/Windhover Information’s "Investment In Innovation (In3) East” Conference
Event Kicks Off with “Medical Device Investor Day” Symposium
October 22-24, 2008, Boston, MA
Irvine, CA August 14, 2008 Medtech Insight, a division of FDC/Windhover, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that 40 early- to late-stage companies are confirmed to date to present at their upcoming “Investment In Innovation (In3) East” conference, being held October 22-24, 2008 at The Westin Copley Place in Boston, MA. Over 50 companies will present on the In3 East stage in all. It is a do-not-miss event for those looking to partner, invest and network with the most promising young medical technology companies on course to impact the worldwide med device market. Preceding In3 East will be a first-of-its-kind “Medical Device Investor Day” symposium, featuring illuminating presentations by approximately 15 of the most influential large companies in the device space (8 are confirmed to date).
The two-day In3 East event – the company’s 32nd In3 conference – will showcase over 50 highly promising start-up med device companies from around the world presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Presenting companies to date (the majority presenting at an In3 event for the first time) include AugmentRx Medical, Inc., Axogen, Inc., BioLineRx, Ltd., BoneGrafix, Cardiola, Ltd., CardioMag Imaging, Inc., Ceragenix Pharmaceuticals, Cerapedics, Inc., Cohera Medical, Inc., Core Essence Orthopaedics LLC, Curative Biosciences, Inc., Delcath Systems, Inc., DermTech International, eCardio Diagnostics, EndoSphere Inc., Envisionier Medical Technologies, EyeMarker Systems, Inc., Genesis Medical Interventional, Inc., Healionics Corporation, HydroCision, Inc., LifeBond Ltd., LineaGen, Inc., MicroTransponder Inc., Minnow Medical, mNemoscience GmbH, MTM Laboratories, nContact Surgical, Inc., Nerites Corporation, Neurobionix, Osprey Medical Inc., PEAK Surgical, Inc., Polymedix, Inc., Sage Technology & Development, Sentinel Group LLC, Sherlock-NMD, Spinal Elements, Symbios Medical, ViOptix Inc., Vivostat A/S, and Xylos Corporation, among many others being added to the program regularly.
The single-track In3 East format will include focused 10-minute presentations by a senior executive from each presenting company in one main ballroom, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The program will also feature an informative panel discussion entitled “Stories Behind How Financing Deals Got Done,” with panelists to include David Milne, Managing Partner, SV Life Science Advisers LP; Kevin Connors, General Partner, Spray Venture Partners; and Amir Nashat, General Partner, Polaris Ventures. A presenting company product exhibition and networking reception will take place on Thursday evening, October 23. A second interactive panel discussion, “FDA Update: Tips for Smooth and Successful Interactions with CDRH,” will be held on Friday morning, October 24.
In3 East sponsors include AdvaMed, Averion, Battelle, Business Wire, Edwards Angell Palmer & Dodge, MDMA, Medmarc and The Hartford, Medical Capital Advisors, Push-Med, The MedTech Group, Ronald Trahan Associates, TATRC, and FDC Reports’ The Gray Sheet. The In3 East registration fee is $1495 through August 31st ($200 off the regular rate), $1695 per attendee after this date, with additional discounts available when registering multiple attendees. Visit www.windhover.com/in3east08 for regularly updated event details.
The Medical Device Investor Day Symposium, being held October 22, will showcase illuminating presentations by approximately 15 of the most influential large companies in the device space. Senior executives from each of these hand-selected companies will speak candidly on what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also inform our audience about partnering opportunities, how companies can maximize their visibility in front of large company investors, and what role M&A plays at their companies. The eight confirmed presenting companies for Investor Day to date include 3M, B. Braun Medical, Becton Dickinson (BD), Boston Scientific, Covidien, Ethicon, a Johnson & Johnson Company, Medtronic, and Stryker, among other industry-leading companies being added regularly to the program. David Cassak, Managing Partner at Windhover Information, kicks off this exciting day with an opening keynote address on the state of larger medical technology company M&A and deal trends. He will be discussing which investment models for larger companies are working, how larger companies are sustaining growth and what the current and future appetite is for M&A. Investor Day is a must-attend event for those interested in what the leaders of the med device industry are thinking, doing, and planning in terms of investment. The registration rate for Medical Device Investor Day only is $795, or this is discounted to $495 when registering for In3 East at the same time. Visit www.windhover.com/investorday for more information.
Medtech Insight and its parent company, FDC/Windhover, an Elsevier company, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1400 emerging medical technology company presenters and over 7500 attendees have participated at In3 events over the past 7 years.
Medtech Insight and FDC/Windhover will also hold their “Investment In Innovation (In3) West” conference at The Palazzo in Las Vegas, NV, March 2-4, 2009, followed by “Investment In Innovation (In3) Europe” at the Marriott Rive Gauche Hotel in Paris, April 29-30.
Contacts:
Medtech Insight, a division of FDC/Windhover, an Elsevier company
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
www.medtechinsight.com
